$Humanigen, Inc.(HGEN)$ $HGEN
UK’s MHRA accepts Humanigen’s submission of Lenzilumab for Marketing Authorization in COVID-19 for expedited rolling review
Despite surging cases , UK still plans a full reopening on July 17th. We can only hope that the MHRA have earmarked accelerated authorization for Lenzilumab to treat patients that become hospitalized as a result of this disastrous political decision.
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
1
举报
登录后可参与评论
暂无评论